Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04998669
Title Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Juan P. Alderuccio, MD
Indications

follicular lymphoma

Therapies

Loncastuximab tesirine-lpyl + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.